Updated results from MONALEESA-2, a phase III trial of first-line ribociclib plus letrozole versus placebo plus letrozole in hormone receptor-positive, HER2-negative advanced breast cancer
Hortobagyi, G.N., Stemmer, S.M., Burris, H.A., Yap, Y.S., Sonke, G.S., Paluch-Shimon, S., Campone, M., Petrakova, K., Blackwell, K.L., Winer, E.P., Janni, W., Verma, S., Conte, P., Arteaga, C.L., Cameron, D.A., Mondal, S., Su, F., Miller, M., Elmeliegy, M., Germa, C., O’Shaughnessy, J.
Published in Annals of oncology (01.07.2018)
Published in Annals of oncology (01.07.2018)
Get full text
Journal Article
P169 Clinical outcomes in patients (pts) with estrogen receptor (ER)+ stage I breast cancer (BC) and Recurrence Score (RS) 26–30: Real-world data
Rotem, O., Peretz, I., Leviov, M., Kuchuk, I., Itay, A., Tokar, M., Paluch-Shimon, S., Maimon, O., Yerushalmi, R., Drumea, K., Evron, E., Sonnenblick, A., Gal-Yam, E., Goldvaser, H., Yosef, S., Merose, R., Bareket-Samish, A., Soussan-Gutman, L., Stemmer, S.M.
Published in Breast (Edinburgh) (01.04.2023)
Published in Breast (Edinburgh) (01.04.2023)
Get full text
Journal Article
CF102 an A3 adenosine receptor agonist mediates anti-tumor and anti-inflammatory effects in the liver
Cohen, S., Stemmer, S.M., Zozulya, G., Ochaion, A., Patoka, R., Barer, F., Bar-Yehuda, S., Rath-Wolfson, L., Jacobson, K.A., Fishman, P.
Published in Journal of cellular physiology (01.09.2011)
Published in Journal of cellular physiology (01.09.2011)
Get full text
Journal Article
Rational design of combination therapies and blockage of acquired targeted drug resistance
Reuveni, H, Kupershmidt, L, Carmi, S, Moskovitz, N, Rozen, M, Shlapoberski, M, Golomb, E, Lotem, M, Stemmer, S.M, Haviv, I
Published in European journal of cancer (1990) (01.07.2016)
Published in European journal of cancer (1990) (01.07.2016)
Get full text
Journal Article
Ribociclib + letrozole for first-line treatment of HR+, HER2− ABC: efficacy, safety, and pharmacokinetics
André, F, Stemmer, S.M, Hortobagyi, G.N, Burris, H.A, Paluch-Shimon, S, Campone, M, Villanueva, C, Chan, A, Wist, E, Marschner, N, Bachelot, T, Blau, S, Janni, W, Verma, S, Conte, P, Dhuria, S, Yang, S, Stegert, M, Germa, C, Arteaga, C.L
Published in European journal of cancer (1990) (01.12.2016)
Published in European journal of cancer (1990) (01.12.2016)
Get full text
Journal Article
1800 Final results for overall survival (OS), the primary endpoint of the CECOG TURANDOT prospective randomised trial evaluating bevacizumab-paclitaxel (BEV-PAC) vs BEV-capecitabine (CAP) for HER2-negative locally recurrent/metastatic breast cancer (LR/mBC)
Zielinski, C.C, Lang, I, Inbar, M, Kahan, Z, Greil, R, Beslija, S, Stemmer, S.M, Zvirbule, Z, Steger, G.G, Melichar, B, Pienkowski, T, Sirbu, D, Petruzelka, L, Eniu, A, Nisenbaum, B, Dank, M, Anghel, R, Messinger, D, Brodowicz, T
Published in European journal of cancer (1990) (01.09.2015)
Published in European journal of cancer (1990) (01.09.2015)
Get full text
Journal Article
Safety results from a phase III study (TURANDOT trial by CECOG) of first-line bevacizumab in combination with capecitabine or paclitaxel for HER-2-negative locally recurrent or metastatic breast cancer
Lang, I, Inbar, M.J, Kahán, Z, Greil, R, Beslija, S, Stemmer, S.M, Kaufman, B, Zvirbule, Z, Steger, G.G, Messinger, D, Brodowicz, T, Zielinski, C
Published in European journal of cancer (1990) (01.11.2012)
Published in European journal of cancer (1990) (01.11.2012)
Get full text
Journal Article
433 Recurrence Score (RS) and Treatment Decisions in Node-positive (N+), Estrogen Receptor-positive (ER+) Breast Cancer Patients in Israel
Stemmer, S.M, Lieberman, N, Efrat, N, Geffen, D.B, Steiner, M, Soussan-Gutman, L, Merling, S, Rizel, S, Klang, S.H
Published in European journal of cancer (1990) (01.03.2012)
Published in European journal of cancer (1990) (01.03.2012)
Get full text
Journal Article
342 INVITED The Role of Opioids in Alleviating Cancer-Related Dyspnea
Ben Aharon, I, Gafter-Gvili, A, Paul, M, Leibovici, L, Stemmer, S.M
Published in European journal of cancer (1990) (2011)
Published in European journal of cancer (1990) (2011)
Get full text
Journal Article
1411 CF102 FOR THE TREATMENT OF HEPATOCELLULAR CARCINOMA: A PHASE I/II, OPEN-LABEL, DOSE-ESCALATION STUDY
Stemmer, S.M, Benjaminov, O, Medalia, G, Ciuraru, N.B, Silverman, M.H, Bar-Yehuda, S, Fishman, S, Harpaz, Z, Farbstein, M, Cohen, S, Patoka, R, Singer, B, Kerns, W.D, Fishman, P
Published in Journal of hepatology (01.04.2012)
Published in Journal of hepatology (01.04.2012)
Get full text
Journal Article
5053 POSTER Randomized Phase III Study of First-line Bevacizumab in Combination With Capecitabine or Paclitaxel for HER2-negative LR/MBC: Interim Safety Data
Inbar, M, Lang, I, Kahán, Z, Greil, R, Beslija, S, Stemmer, S.M, Kaufman, B, Zvirbule, Z, Steger, G.G, Zielinski, C.C
Published in European journal of cancer (1990) (2011)
Published in European journal of cancer (1990) (2011)
Get full text
Journal Article
924 CF102 INDUCES APOPTOSIS OF LIVER CANCER WHILE PREVENTING APOPTOSIS IN LIVER INFLAMMATION: A NEW APPROACH TO TREAT LIVER DISEASES
Cohen, S, Stemmer, S.M, Zozulya, G, Ochaion, A, Patoka, R, Barer, F, Bar Yehuda, S, Rath-Wolfson, L, Fishman, P
Published in Journal of hepatology (2010)
Published in Journal of hepatology (2010)
Get full text
Journal Article
Incidence and outcomes of osteonecrosis of the jaw from an integrated analysis of three pivotal randomized double-blind, double-dummy phase 3 trials comparing denosumab and zoledronic acid for treatment of bone metastases in advanced cancer patients or myeloma
Brown, J.E, Barrios, C.H, Diel, I.J, Facon, T, Fizazi, K, Ibrahim, T, Saad, F, Senecal, F, Stemmer, S.M, Stopeck, A, Takahashi, S, Van Poznak, C, Zhou, L, Carriere, P, Daniels, A, Dansey, R
Published in Bone (New York, N.Y.) (01.01.2011)
Published in Bone (New York, N.Y.) (01.01.2011)
Get full text
Journal Article
Time course and management of key adverse events during the randomized phase III SOLAR-1 study of PI3K inhibitor alpelisib plus fulvestrant in patients with HR-positive advanced breast cancer
Rugo, H.S., André, F., Yamashita, T., Cerda, H., Toledano, I., Stemmer, S.M., Jurado, J.C., Juric, D., Mayer, I., Ciruelos, E.M., Iwata, H., Conte, P., Campone, M., Wilke, C., Mills, D., Lteif, A., Miller, M., Gaudenzi, F., Loibl, S.
Published in Annals of oncology (01.08.2020)
Published in Annals of oncology (01.08.2020)
Get full text
Journal Article
1257MO ABBV-400, a c-Met protein-targeting antibody-drug conjugate (ADC), in patients (Pts) with advanced EGFR wildtype (WT) non-squamous (NSQ) non-small cell lung cancer (NSCLC): Results from a phase I study
De Miguel, M., yamamoto, N., Raimbourg, J., Cho, B.C., Gottfried, M., Stemmer, S.M., Goldman, J.W., Blaney, M.E., Jennaro, T., Vasilopoulos, A., Li, R.R., Freise, K.J., Neagu Aristide, M.R., Morrison-Thiele, G., Hunter, Z.N., Burns, M., Camidge, D.R.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
Cryopreservation of in vitro matured oocytes in addition to ovarian tissue freezing for fertility preservation in paediatric female cancer patients before and after cancer therapy
Abir, R., Ben-Aharon, I., Garor, R., Yaniv, I., Ash, S., Stemmer, S.M., Ben-Haroush, A., Freud, E., Kravarusic, D., Sapir, O., Fisch, B.
Published in Human reproduction (Oxford) (01.04.2016)
Published in Human reproduction (Oxford) (01.04.2016)
Get full text
Journal Article
Circulating tumour DNA (ctDNA) identifies actionable genetic alterations in Middle Eastern and Asian (MEA) patients diagnosed with carcinoma of unknown primary (CUP)
Peled, N., Okuma, H., Rotem, O., Dudnik, E., Ikeda, S., Stemmer, S.M., Olsen, S.
Published in Annals of oncology (01.11.2019)
Published in Annals of oncology (01.11.2019)
Get full text
Journal Article